Pavanni Ratnagopal

2.6k total citations
53 papers, 1.6k citations indexed

About

Pavanni Ratnagopal is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Pavanni Ratnagopal has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Neurology, 15 papers in Cellular and Molecular Neuroscience and 13 papers in Molecular Biology. Recurrent topics in Pavanni Ratnagopal's work include Parkinson's Disease Mechanisms and Treatments (24 papers), Peripheral Neuropathies and Disorders (11 papers) and RNA regulation and disease (8 papers). Pavanni Ratnagopal is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (24 papers), Peripheral Neuropathies and Disorders (11 papers) and RNA regulation and disease (8 papers). Pavanni Ratnagopal collaborates with scholars based in Singapore, United States and China. Pavanni Ratnagopal's co-authors include Eng‐King Tan, Stephanie Fook‐Chong, Yi Zhao, Martin C. S. Wong, Hui Shen, Louis C.S. Tan, Lisa Skipper, Yew Long Lo, Yuen Yih and V. R. Chandran and has published in prestigious journals such as PLoS ONE, Neurology and Scientific Reports.

In The Last Decade

Pavanni Ratnagopal

53 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pavanni Ratnagopal Singapore 22 1.2k 493 396 343 258 53 1.6k
Helen Mejia‐Santana United States 21 1.2k 1.0× 395 0.8× 316 0.8× 253 0.7× 550 2.1× 29 1.5k
Hsin Fen Chien Brazil 16 858 0.7× 309 0.6× 275 0.7× 242 0.7× 234 0.9× 40 1.3k
Laura Vacca Italy 21 1.6k 1.3× 468 0.9× 316 0.8× 180 0.5× 158 0.6× 58 1.8k
Eng-King Tan Singapore 16 783 0.7× 359 0.7× 176 0.4× 388 1.1× 285 1.1× 30 1.2k
Yi‐Hsin Weng Taiwan 18 632 0.5× 335 0.7× 318 0.8× 369 1.1× 161 0.6× 33 1.0k
Tàmara Ialongo Italy 19 1.2k 1.0× 673 1.4× 283 0.7× 360 1.0× 237 0.9× 25 1.5k
Katerina Markopoulou United States 21 840 0.7× 419 0.8× 295 0.7× 366 1.1× 482 1.9× 50 1.5k
Avner Thaler Israel 21 973 0.8× 189 0.4× 215 0.5× 177 0.5× 430 1.7× 71 1.3k
Masahiko Tomiyama Japan 26 1.4k 1.2× 1.2k 2.5× 210 0.5× 421 1.2× 266 1.0× 132 2.2k
Alessandro Ferraris Italy 21 595 0.5× 593 1.2× 184 0.5× 422 1.2× 150 0.6× 46 1.4k

Countries citing papers authored by Pavanni Ratnagopal

Since Specialization
Citations

This map shows the geographic impact of Pavanni Ratnagopal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavanni Ratnagopal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavanni Ratnagopal more than expected).

Fields of papers citing papers by Pavanni Ratnagopal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavanni Ratnagopal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavanni Ratnagopal. The network helps show where Pavanni Ratnagopal may publish in the future.

Co-authorship network of co-authors of Pavanni Ratnagopal

This figure shows the co-authorship network connecting the top 25 collaborators of Pavanni Ratnagopal. A scholar is included among the top collaborators of Pavanni Ratnagopal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavanni Ratnagopal. Pavanni Ratnagopal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeo, Tianrong, et al.. (2022). COVID-19 infection after two doses of SARS-CoV-2 mRNA vaccine in multiple sclerosis, AQP4-antibody NMOSD and MOGAD. Multiple Sclerosis and Related Disorders. 65. 104003–104003. 9 indexed citations
2.
Ratnagopal, Pavanni, et al.. (2020). Multiple sclerosis with intractable vomiting and atypical area postrema lesion. Multiple Sclerosis and Related Disorders. 45. 102348–102348. 5 indexed citations
3.
Yong, Ming‐Hui, et al.. (2011). Case Control Polysomnographic Studies of Sleep Disorders in Parkinson's Disease. PLoS ONE. 6(7). e22511–e22511. 112 indexed citations
4.
Tan, Eng‐King, Chun‐Hwei Tai, Louis C.S. Tan, et al.. (2009). Non-synonymous GIGYF2 variants in Parkinson’s disease from two Asian populations. Human Genetics. 126(3). 425–430. 16 indexed citations
5.
Fook‐Chong, Stephanie, et al.. (2008). The Laterality Index in the Evaluation of Distal Sensorimotor Neuropathy. Journal of Clinical Neuromuscular Disease. 10(1). 18–21. 6 indexed citations
6.
Loh, Yvonne, William Ying Khee Hwang, & Pavanni Ratnagopal. (2007). Autologous Haematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis. Annals of the Academy of Medicine Singapore. 36(6). 421–426. 3 indexed citations
7.
Tan, Eng‐King, Yi Zhao, Louis C.S. Tan, et al.. (2007). Analysis of LRRK2 Gly2385Arg genetic variant in non‐Chinese Asians. Movement Disorders. 22(12). 1816–1818. 24 indexed citations
8.
Lo, Yew Long & Pavanni Ratnagopal. (2007). Cortico-hypoglossal and corticospinal conduction abnormality in Bickerstaff's brainstem encephalitis. Clinical Neurology and Neurosurgery. 109(6). 523–525. 6 indexed citations
9.
Zhao, Yi, E. Chua, Hai‐Yang Law, et al.. (2006). Genetic analysis of SCA2, 3 and 17 in idiopathic Parkinson's disease. Neuroscience Letters. 403(1-2). 11–14. 22 indexed citations
10.
Prakash, K.M., Pavanni Ratnagopal, K. Puvanendran, & Yen‐Shi Lo. (2006). Mycophenolate mofetil – as an adjunctive immunosuppressive therapy in refractory myasthenia gravis: The Singapore experience. Journal of Clinical Neuroscience. 14(3). 278–281. 10 indexed citations
11.
Skipper, Lisa, Yi Li, Carine Bonnard, et al.. (2005). Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease. Human Molecular Genetics. 14(23). 3549–3556. 62 indexed citations
12.
Tan, Eng‐King, Hui Shen, Louis C.S. Tan, et al.. (2005). The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neuroscience Letters. 384(3). 327–329. 120 indexed citations
13.
Ratnagopal, Pavanni, et al.. (2004). Effect of Exercise on Repetitive Nerve Stimulation Studies: New Appraisal of an Old Technique. Journal of Clinical Neurophysiology. 21(2). 110–113. 13 indexed citations
14.
Lo, Yew Long, Ling Ling Chan, Winston Shang Rong Lim, et al.. (2004). Systematic Correlation of Transcranial Magnetic Stimulation and Magnetic Resonance Imaging in Cervical Spondylotic Myelopathy. Spine. 29(10). 1137–1145. 43 indexed citations
15.
Lo, Yew Long, et al.. (2003). Decrement in area of muscle responses to repetitive nerve stimulation. Muscle & Nerve. 27(4). 494–496. 15 indexed citations
16.
Tan, Eng‐King, Pavanni Ratnagopal, Song Yi Han, & M.C. Wong. (2003). Piribedil and bromocriptine in Parkinson's disease: a single-blind crossover study. Acta Neurologica Scandinavica. 107(3). 202–206. 14 indexed citations
17.
Tan, Eng‐King, Celia Ia Choo Tan, Stephanie Fook‐Chong, et al.. (2003). Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese. Journal of the Neurological Sciences. 216(1). 163–167. 138 indexed citations
18.
Lo, Yew Long, et al.. (2002). Clinical and electrophysiological aspects of distal ulnar neuropathy. Acta Neurologica Scandinavica. 105(5). 390–394. 10 indexed citations
19.
Lo, Yew Long, et al.. (2002). Repetitive hypoglossal nerve stimulation in myasthenia gravis. Clinical Neurophysiology. 113(8). 1227–1230. 14 indexed citations
20.
Lo, Yew Long, et al.. (2001). Segmental Mixed Nerve Conduction Studies in Ulnar Neuropathy at the Elbow. Journal of Clinical Neurophysiology. 18(5). 456–459. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen Mejia‐Santana Breakdown of academic impact, for papers by Hsin Fen Chien Breakdown of academic impact, for papers by Laura Vacca Breakdown of academic impact, for papers by Eng-King Tan Breakdown of academic impact, for papers by Yi‐Hsin Weng Breakdown of academic impact, for papers by Tàmara Ialongo Breakdown of academic impact, for papers by Katerina Markopoulou Breakdown of academic impact, for papers by Avner Thaler Breakdown of academic impact, for papers by Masahiko Tomiyama Breakdown of academic impact, for papers by Alessandro Ferraris
Rankless by CCL
2026